How to Manage GLP-1 Prescription Costs in Your Employee Health Plan Without Eliminating Coverage

Schedule Now

How to Manage GLP-1 Prescription Costs in Your Employee Health Plan Without Eliminating Coverage: Effective Employer Strategies for 2026

GLP-1 prescription costs have become one of the fastest-growing drivers of pharmacy benefit expenses in employer health plans nationwide. For Michigan employers, managing employee health plan costs related to GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound is a critical challenge in 2026. CFH Insurance Consultants, a trusted independent employee benefits broker serving Michigan employers with 50 to 500 employees, specializes in helping businesses navigate these rising costs without eliminating essential coverage.

With average annual costs for GLP-1 medications ranging from $12,000 to $16,000 per member, these drugs are significantly impacting employer health plan budgets. This article provides a practical, expert-led guide for Michigan employers on managing GLP-1 prescription costs effectively while maintaining comprehensive employee health benefits.

We will explore the nature of GLP-1 drugs, the local Michigan market context, proven cost management strategies, and the financial impact of these medications on employer health plans. Additionally, we will highlight how CFH Insurance Consultants supports Michigan employers in designing balanced GLP-1 coverage policies that protect employee health and control costs.

What Are GLP-1 Drugs and Why Are They Driving Up Employer Health Plan Costs?

GLP-1 drugs, or glucagon-like peptide-1 receptor agonists, are a class of medications used primarily to treat type 2 diabetes and obesity. The major GLP-1 medications include:

• Semaglutide: marketed as Ozempic for diabetes and Wegovy for obesity
• Tirzepatide: marketed as Mounjaro for diabetes and Zepbound for obesity
• Liraglutide: marketed as Victoza for diabetes and Saxenda for obesity

These medications have high list prices before rebates: Ozempic costs approximately $935 per month, Wegovy about $1,350 per month, Mounjaro around $1,023 per month, and Zepbound roughly $1,060 per month.

Employer costs for GLP-1 drugs have surged due to a 300%+ increase in utilization between 2021 and 2024. The approval of obesity-specific GLP-1 drugs like Wegovy and Zepbound has expanded the eligible population beyond diabetes management, further driving up costs. Importantly, the Affordable Care Act (ACA) does not mandate employers to cover GLP-1 drugs for obesity, making coverage a voluntary decision for employers.

Pharmacy Benefit Managers (PBMs) and formulary design play key roles in managing GLP-1 costs. PBMs negotiate rebates and manage drug formularies, which can influence coverage policies and out-of-pocket costs for employees.

GLP-1 Coverage for Michigan Employers: Local Market Context and Carrier Policies

Michigan’s employer health plan landscape features several major fully insured carriers, including Blue Cross Blue Shield of Michigan, Priority Health, HAP, and McLaren Health Plan. These carriers have varying policies regarding GLP-1 coverage:

• Some carriers cover obesity-indicated GLP-1 drugs with prior authorization requirements
• Others restrict coverage to diabetes-indicated use only

Self-funded Michigan employers have full flexibility under ERISA to design their own GLP-1 coverage policies, independent of state insurance mandates. This allows for tailored plan designs that balance cost and coverage.

Obesity rates in Michigan are above the national average, with approximately 36% of adults classified as obese according to Michigan Department of Health and Human Services (DHHS) data. This makes managing GLP-1 prescription costs especially important for Michigan employers.

Michigan’s largest employment sectors, including manufacturing and healthcare, are experiencing disproportionate GLP-1 cost increases due to workforce demographics. CFH Insurance Consultants has extensive experience helping Michigan employers in these sectors design GLP-1 coverage policies that optimize employee health outcomes while maintaining plan cost sustainability.

CFH works closely with Michigan employers to evaluate carrier formulary options, PBM contracts, and clinical management programs for GLP-1 drugs, ensuring coverage decisions align with both employee needs and budget constraints.

Proven Strategies for Managing GLP-1 Prescription Costs in Your Employee Health Plan

Employers can implement several effective strategies to manage GLP-1 prescription costs while maintaining employee access to these important medications:

1. Prior Authorization Requirements: Require clinical criteria such as BMI thresholds, comorbidities, and failed alternative treatments before approving GLP-1 coverage.
2. Step Therapy Protocols: Mandate use of lower-cost diabetes or weight management interventions before GLP-1 drugs are approved.
3. Indication-Based Coverage: Cover GLP-1 drugs for type 2 diabetes management but exclude coverage for obesity or weight loss only indications.
4. Quantity Limits and Refill Management: Limit days’ supply and require ongoing clinical engagement for continued coverage.
5. Specialty Pharmacy Carve-Outs: Direct GLP-1 prescriptions to specialty pharmacies with better rebate contracts.
6. Value-Based Coverage Design: Tie GLP-1 coverage to participation in wellness programs, weight management coaching, or diabetes management programs.
7. PBM Rebate Optimization: Work with a benefits broker like CFH Insurance Consultants to negotiate better rebate contracts, which can offset 30–50% of list price costs.

CFH Insurance Consultants helps Michigan employers implement clinical management programs that reduce GLP-1 prescription costs while maintaining employee access to these critical therapies.

The Real Cost of GLP-1 Drugs on Michigan Employer Health Plans

Consider a Michigan employer with 200 employees and a 5% GLP-1 utilization rate. Annual GLP-1 pharmacy costs could range from $120,000 to $160,000, representing a significant portion of the health plan budget.

However, the return on investment (ROI) for GLP-1 coverage can be substantial. Studies show these drugs reduce cardiovascular events, hospitalizations, and diabetes complications, leading to long-term cost offsets for employers with high-risk populations.

Self-funded employers benefit from full claims transparency, enabling them to identify GLP-1 cost trends through detailed claims data. Fully insured employers should request pharmacy utilization reports from their carriers to monitor these costs.

CFH Insurance Consultants offers financial modeling services to project GLP-1 costs for Michigan employers, helping inform coverage design decisions that balance cost and employee health outcomes.

What Are GLP-1 Medications and Why Are They Important for Employee Health Plans?

GLP-1 medications, or glucagon-like peptide-1 receptor agonists, are a class of drugs that play a crucial role in managing obesity and diabetes. These medications work by mimicking the effects of the GLP-1 hormone, which helps regulate appetite and insulin secretion. By promoting weight loss and improving glycemic control, GLP-1 medications can significantly enhance employee health and productivity. As obesity and diabetes rates continue to rise, incorporating GLP-1 medications into employee health plans is becoming increasingly vital for employers looking to support their workforce’s health.

How Do GLP-1 Drugs Support Obesity and Diabetes Management in Employees?

GLP-1 drugs support obesity and diabetes management by enhancing insulin secretion in response to meals and reducing appetite. This dual action not only aids in weight loss but also helps stabilize blood sugar levels, which is essential for employees managing diabetes. Studies have shown that employees using GLP-1 medications can experience significant weight loss, leading to improved overall health and reduced healthcare costs for employers. By investing in these medications, employers can foster a healthier workforce, ultimately benefiting their bottom line.

What Is the FDA Approval Status and Market Trend for GLP-1 Medications in 2026?

As of 2026, several GLP-1 medications have received FDA approval, reflecting a growing recognition of their importance in treating obesity and diabetes. The market for these medications is expected to expand significantly, driven by increasing awareness of their benefits and the rising prevalence of obesity-related health issues. Employers should stay informed about these trends to ensure their health plans remain competitive and effective in meeting employee needs.

Which Employer Health Plan Options Include Coverage for Obesity Drugs Like GLP-1?

Employers have various health plan options that can include coverage for GLP-1 medications. Understanding these options is crucial for ensuring that employees have access to necessary treatments while managing costs effectively.

How Do Group Health Insurance Plans Integrate GLP-1 Drug Benefits?

Group health insurance plans can integrate GLP-1 drug benefits by including them in their formulary, which outlines the medications covered under the plan. Employers should work with their insurance providers to ensure that GLP-1 medications are included, as this can significantly impact employee health outcomes. Additionally, offering these medications as part of a comprehensive benefits package can enhance employee satisfaction and retention.

What Roles Do QSEHRA and ICHRA Play in Prescription Drug Coverage for Small Businesses?

Qualified Small Employer Health Reimbursement Arrangements (QSEHRA) and Individual Coverage Health Reimbursement Arrangements (ICHRA) provide small businesses with flexible options for offering health benefits, including prescription drug coverage. These arrangements allow employers to reimburse employees for out-of-pocket expenses related to GLP-1 medications, making it easier for small businesses to support their employees’ health needs without incurring high insurance premiums.

What Cost Management Strategies Can Employers Use to Control GLP-1 Prescription Expenses?

Employers can implement several cost management strategies to control GLP-1 prescription expenses while maintaining coverage for their employees. These strategies can help balance the need for effective treatments with the financial realities of providing health benefits.

The challenge is further compounded by the often unpredictable nature of these expenses, which can significantly influence an employer’s benefits decisions.

Managing Unpredictable GLP-1 Costs in Employee Health Plans

GLP-1 obesity medication coverage among 247 healthcare organizations is associated with significant and unpredictable costs associated with GLP-1 RA therapies, impacting decisions regarding offering or maintaining employee health insurance plans.

Negative Consequences of Removing GLP‐1 RA Obesity Coverage: A Cross‐

Sectional Cohort Comparison Study, JM Francis, 2026

1. Negotiating Insurance Rates: Employers can negotiate with insurance providers to secure better rates for GLP-1 medications, potentially lowering overall costs.
2. Implementing Reference-Based Pricing: This strategy involves setting a maximum reimbursement amount for GLP-1 medications, encouraging employees to seek cost-effective options.
3. Utilizing Technology for Cost Management: Employers can leverage technology, such as pharmacy benefit management systems, to monitor prescription costs and identify opportunities for savings.

Among the various tools available, pharmacy benefit managers (PBMs) play a crucial role in implementing diverse strategies and techniques to manage prescription drug program costs.

PBM Strategies for Prescription Drug Cost Control

With increased attention focused on prescription drug programs, expenditures, and coverage, interest also has increased in drug program cost control measures, in particular those of pharmacy benefit managers (PBMs). PBMs have had a central functional role in prescription drug coverage plans built around claims processing and program administration activities. A number of strategies and techniques to control cost in drug programs have been used by PBMs.

Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager PBM Efforts, Effects, and Implications, 2000

How Can QSEHRA and ICHRA Effectively Reimburse GLP-1 Drug Costs?

QSEHRA and ICHRA can effectively reimburse GLP-1 drug costs by allowing employers to set specific reimbursement limits and criteria for eligible expenses. This flexibility enables small businesses to provide meaningful support for employees managing obesity and diabetes without overwhelming their budgets. By clearly communicating the reimbursement process and eligibility requirements, employers can enhance employee understanding and utilization of these benefits.

What Are Proven Methods to Balance Coverage and Cost Control for Obesity Medications?

Balancing coverage and cost control for obesity medications requires a strategic approach that considers both employee health needs and financial constraints. Proven methods include:

1. Negotiating Insurance Rates: Engaging in discussions with insurance providers to secure favorable terms for GLP-1 medications.
2. Implementing Wellness Programs: Encouraging healthy lifestyle choices among employees can reduce the overall demand for medications.
3. Regular Plan Reviews: Conducting periodic reviews of health plans to assess the effectiveness of GLP-1 coverage and make necessary adjustments.

How Have Small Businesses Successfully Managed GLP-1 Prescription Costs in Their Health Plans?

Small businesses have successfully managed GLP-1 prescription costs by adopting innovative strategies tailored to their unique needs. These strategies often involve leveraging available resources and collaborating with insurance providers to optimize health plan offerings.

What Case Studies Demonstrate Cost Savings Using Reimbursement Arrangements?

Several case studies illustrate how small businesses have achieved cost savings through reimbursement arrangements. For instance, a small tech company implemented a QSEHRA to reimburse employees for GLP-1 medication costs, resulting in increased employee satisfaction and reduced absenteeism due to health issues. This approach not only supported employee health but also contributed to the company’s overall productivity.

Which Best Practices Improve Employee Benefits While Controlling GLP-1 Drug Expenses?

Best practices for improving employee benefits while controlling GLP-1 drug expenses include:

1. Customization of Benefits: Tailoring health plans to meet the specific needs of employees can enhance satisfaction and utilization.
2. Employee Education Initiatives: Providing resources and information about GLP-1 medications can empower employees to make informed decisions about their health.
3. Negotiating with Brokers: Collaborating with insurance brokers to identify cost-effective solutions for GLP-1 coverage can lead to significant savings.

What Regulatory and Market Trends Affect GLP-1 Coverage in Employee Health Plans?

Regulatory and market trends play a significant role in shaping GLP-1 coverage in employee health plans. Staying informed about these trends is essential for employers looking to provide effective health benefits.

How Do FDA Approvals and IRS Guidelines Impact Prescription Drug Benefits?

FDA approvals and IRS guidelines directly impact prescription drug benefits by determining which medications are eligible for coverage and reimbursement. Employers must stay updated on these regulations to ensure compliance and optimize their health plans.

What Emerging Trends Should Employers Monitor for Obesity Drug Coverage in 2026?

Emerging trends in obesity drug coverage include the increasing acceptance of GLP-1 medications as standard treatment options and the growing emphasis on preventive care. Employers should monitor these trends to adapt their health plans accordingly and ensure they meet the evolving needs of their workforce.

How Can Employers Optimize Their Employee Benefits Communication and Plan Design for GLP-1 Coverage?

Effective communication and thoughtful plan design are crucial for optimizing employee benefits related to GLP-1 coverage. Employers should focus on clear messaging and accessible resources to enhance employee understanding and engagement.

What Internal Linking and Structured Data Strategies Enhance Plan Transparency?

Implementing internal linking and structured data strategies can enhance plan transparency by making it easier for employees to access information about their benefits. This approach fosters a better understanding of GLP-1 coverage and encourages employees to utilize available resources.

How Do Visual Tools Like Infographics and Flowcharts Support Employee Understanding?

Visual tools, such as infographics and flowcharts, can significantly improve employee understanding of GLP-1 coverage and the reimbursement process. By presenting complex information in a visually appealing format, employers can enhance engagement and facilitate better decision-making among employees.

Frequently Asked Questions

About CFH Insurance Consultants

CFH Insurance Consultants is a licensed independent employee benefits broker serving Michigan employers with 50 to 500 employees. Our team specializes in pharmacy benefit management and health plan cost containment, with deep expertise in GLP-1 prescription cost strategies. Our licensed advisors have helped Michigan employers across Grand Rapids, Detroit, Lansing, and Oakland County develop GLP-1 coverage strategies that protect employee health while controlling pharmacy benefit costs.

Written by the CFH Insurance Consultants Advisory Team — licensed employee benefits specialists with expertise in pharmacy benefit management, GLP-1 cost containment, and health plan design for Michigan employers.

Reviewed by a licensed Michigan employee benefits specialist to ensure accuracy and relevance.

Conclusion

GLP-1 prescription costs present a significant challenge for Michigan employers managing employee health plan costs in 2026. With rapidly rising utilization and high drug prices, employers must adopt strategic approaches to maintain coverage while controlling expenses. Proven strategies such as prior authorization, step therapy, specialty pharmacy carve-outs, and PBM rebate optimization can help balance these competing priorities.

CFH Insurance Consultants stands ready to partner with Michigan employers to design and implement effective GLP-1 coverage policies tailored to local market conditions and workforce needs. Our expertise in pharmacy benefit management and health plan design ensures that employers can protect employee health without compromising financial sustainability.

Schedule Your Free GLP-1 Cost Management Consultation

Contact CFH Insurance Consultants today to receive a complimentary pharmacy benefit and GLP-1 prescription cost management consultation tailored for Michigan employers. Let us help you optimize your employee health plan costs while maintaining essential coverage.